Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis

Scandinavian Journal of Immunology

Volumn 44, Issue 6, 1996, Pages 623-629

  Homann, C ^a,c   Hansen, M B ^b   Graudal, N ^a   Hasselqvist, P ^a   Svenson, M ^b   Bendtzen, K ^b   Thomsen, A C ^a   Garred, P ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 6;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; RISK;

EID: 0029800642     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-344.x     Document Type: Article

References (41)

1. Felver ME, Mezey E, McGuire M et al. Plasma tumor necrosis factor α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990;14:255-9.
2. Bird GLA, Sheron N, Goka J, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-20.
3. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13:267-76.
4. Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 1991;84:449-53.
5. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992;119:547-52.
6. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
7. Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J. Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993;104:1492-7.
8. Ruiz AD, Perez JLS, Martinez GP, Calvin JG, Extremera BG, Gea FG. Tumor necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis. Alcohol-Alcohol 1993;28:319-23.
9. Deviere J, Content J, Denys C et al. High interleukin-6 serum levels and increased production by leukocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol 1989;77:221-5.
10. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989;9:349-51.
11. Deviere J, Content J, Denys C et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11:628-34.
12. McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Sem Liver Dis 1993;13:170-82.
13. Deviere J, Le Moine O, Goldman M, Dupont E. Cytokines in alcoholic liver cirrhosis. In: Gerok W, Decker K, Andus T, Gross V, eds. Cytokines and the Liver. Dordrecht: Kluwer Academic Publishers, 1995;127-37.
14. Svenson M, Poulsen LK, Fomsgaard A, Bendtzen K. IgG autoantibodies against interleukin 1 alpha in sera of normal individuals. Scand J Immunol 1989;29:489-92.
15. Hansen MB, Svenson M, Bendtzen K. Human anti-interleukin 1α antibodies. Immunol Lett 1991;30:133-9.
16. Hansen MB, Svenson M, Diamant M, Bendtzen K. Anti-interleukin-6 antibodies in normal human serum. Scand J Immunol 1991;33:777-81.
17. Svenson M, Hansen MB, Bendtzen K. Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest 1993;92:2533-9.
18. Hansen MB, Svenson M, Diamant M, Bendtzen K. High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine 1993;5:72-80.
19. Hansen MB, Svenson M, Abell K et al. Sex- and age-dependency of IgG autoantibodies against IL-1α in healthy humans. Eur J Clin Invest 1994;24:212-8.
20. Bendtzen K, Svenson M, Jønsson V, Hippe E. Autoantibodies to cytokines - friends or foes. Immunol Today 1990;11:167-9.
21. Hansen MB, Svenson M, Diamant M, Abell K, Bendtzen K. Interleukin-6 autoantibodies: possible biological and clinical significance. Leukemia 1995;9:1113-5.
22. Homann C, Garred P, Graudal N et al. Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis. Hepatology 1995;21:979-85.
23. Suzuki H, Akama T, Okane M et al. Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis. Arthritis Rheum 1989;32:1528-38.
24. Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierijean L. Anti-interleukin-1 α autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition - higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 1991;88:244-56.
25. Takemura H, Suzuki H, Yoshizaki K et al. Anti-interleukin-6 autoantibodies in rheumatic diseases. Increased frequency in the sera of patients with systemic sclerosis. Arthritis Rheum 1992;35:940-3.
26. Suzuki H, Takemura H, Yoshizaki K et al. IL-6-Anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis. J Immunol 1994;152:935-42.
27. Hansen MB, Svenson M, Abell K, Yasukawa K, Diamant M, Bendtzen K. Influence of interleukin 6 (IL-6) autoantibodies on IL-6 binding to cellular receptors. Eur J Immunol 1995; 25:348-54.
28. Finkelman FD, Madden KB, Morris SC et al. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogeneous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol 1993;151:1235-44.
29. Mihara M, Koishihara Y, Fukui H, Yasukawa K, Oshugi Y. Murine anti-human IL-6 monoclonal antibody prolongs the half-life in circulating blood and thus prolongs the bioactivity of human IL-6 in mice. Immunology 1991:74;55-9.
30. Van Snick J. Interleukin-6: An overview. Annu Rev Immunol 1990;8:253-78.
31. van de Wiel A, Delacroix DL, Van Hattum J, Schuurman HJ, Kater L. Characteristics of serum IgA and liver IgA deposits in alcoholic liver disease. Hepatology 1987;7:95-9.
32. Deviere J, Content J, Chantai D et al. Immunoglobulin A and interleukin 6 form a positive secretory feedback loop: a study of normal subjects and alcoholic cirrhotics. Gastroenterology 1992;103:1296-301.
33. Choi I, Kang H-S, Yang Y, Pyun K-H. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol 1994;95:5305.
34. Napoli J, Bishop GA, McCaughan GW. Increased intrahepatic messenger RNA expression of interleukins 2:6 and 8 in human cirrhosis. Gastroenterology 1994;107:789-98.
35. Kopf M, Baumann H, Freer G et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-42.
36. Ramsay AJ, Husband AJ, Ramshaw IA et al. The role of interleukin-6 in mucosal IgA antibody response in vivo. Science 1994;264:561-3.
37. Wyke RJ. Problems of bacterial infection in patients with liver disease. Gut 1987;28:623-41.
38. Graudal N, Hubeck B, Bonde J, Thomsen Å Chr. The prognostic significance of bacteremia in hepatic cirrhosis. Liver 1987;7:137-41.
39. Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988;8:27-31.
40. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18:353-8.
41. Christensen E, Schlichting P, Fauerholdt L et al. Prognostic value of Child-Turcotte Criteria in medically treated cirrhosis. Hepatology 1984;4:430-5.